Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,951–3,975 of 7,816 matching trials · page 159 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease NCT04566003 [18F]GTP1; [18F]PI-2620; [18F]MK-6240 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 40 | Genentech, Inc. INDUSTRY |
2023-07-12 |
|
Results From Objective Brushing Data Saved From a Powered Toothbrush Related to Values for Oral Health NCT05941611 Powered toothbrush Runs in: Sweden · 1 site |
NA other |
COMPLETED | 213 | Blekinge Institute of Technology OTHER |
2023-07-12 |
|
Striatum and Hippocampus on Different Time Scales NCT05943054 Temporal perception tasks Runs in: France · 1 site |
NA other |
UNKNOWN | 104 | Assistance Publique - Hôpitaux de Paris OTHER |
2023-07-12 |
|
The Long-term Effect on Oral Health Using a Powered Toothbrush in Individuals With Mild Cognitive Impairment NCT05939050 Powered toothbrush Runs in: Sweden · 2 sites |
NA other |
COMPLETED | 170 | Blekinge Institute of Technology OTHER |
2023-07-11 |
|
Auricular Point Acupressure to Manage Pain in Patients With Alzheimer's Disease and Related Disorders NCT03393546 Auricular Point Acupressure Runs in: United States · 1 site |
NA other |
TERMINATED | 8 | Johns Hopkins University OTHER |
2023-07-10 |
|
Alcohol Myopia, Objectification, and Sexual Assault NCT03956238 Alcohol intoxication; Objectification Runs in: United States · 1 site |
NA other |
COMPLETED | 359 | University of Nebraska Lincoln OTHER |
2023-07-10 |
|
Risk of Developing Dementia and Associated Factors in Patients With Normal Brain FDG PET NCT04804722 18F-FDG PET-CT (fluorodesoxyglucose positron emission tomography) Runs in: France · 1 site |
NA other |
COMPLETED | 100 | Central Hospital, Nancy, France OTHER |
2023-07-06 |
|
Multifactorial Approach to Dementia, Multicentric Study NCT05923307 Runs in: Argentina · 1 site |
NA other |
UNKNOWN | 450 | Daniel Serrani Azcurra OTHER |
2023-07-06 |
|
Effectiveness of an Intervention Using Observation/Action Therapy Among Patients With Mild Cognitive Impairment NCT05934344 Action observation training Runs in: Spain · 1 site |
NA other |
UNKNOWN | 45 | Universidad Europea de Madrid OTHER |
2023-07-06 |
|
Effect of a fNIRS-based Personalized Multi-domain Intervention on Cognitive in Elderly Population With High Risk of Stroke NCT05930249 Personalized multidomain intervention Runs in: China · 1 site |
NA other |
UNKNOWN | 264 | Second Affiliated Hospital, Zhejiang University, School of Medicine OTHER |
2023-07-05 |
|
Study of the Therapeutic Effects of Naohuan Dan and Idebenone in Treating Mild Cognitive Impairment With Kidney Deficiency and Phlegm Stasis NCT05931029 Idebenone; Naohuan Dan and Idebenone Runs in: China · 1 site |
NA other |
COMPLETED | 64 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University OTHER |
2023-07-05 |
|
Network-Level Mechanisms for Preclinical Alzheimer's Disease Development NCT03461861 AGB101 220 mg; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 26 | Medical College of Wisconsin OTHER |
2023-07-03 |
|
Examining Neuroinflammation in AlzHeimer's NCT03548883 |
NA other |
COMPLETED | 14 | AdventHealth OTHER |
2023-07-03 |
|
Mindfulness-Based Resilience Training for Aggression, Health, and Stress Among Law Enforcement Officers NCT03784846 Mindfulness-Based Resilience Training; Stress Management Education Runs in: United States · 2 sites |
NA other |
COMPLETED | 109 | Pacific University OTHER |
2023-07-03 |
|
PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION NCT03999879 Measure of OxPhos upregulation; lactate (measured with 1H-MRSI) Runs in: United States · 1 site |
NA other |
COMPLETED | 37 | NYU Langone Health OTHER |
2023-07-03 |
|
Validity and Reliability of Turkish Version of Bayer Activities of Daily Living Scale NCT05449626 Assessment Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 400 | Yeditepe University OTHER |
2023-07-03 |
|
E-bibliotherapy for Informal Caregivers of People With Dementia NCT05927805 E-bibliotherapy; Control |
NA other |
NOT_YET_RECRUITING | 192 | The Hong Kong Polytechnic University OTHER |
2023-07-03 |
|
A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase NCT01278407 Donepezil 5 mg; Donepezil 10 mg; Donepezil matched placebo Runs in: Japan · 56 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 142 | Eisai Co., Ltd. INDUSTRY |
2023-06-29 |
|
Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies NCT04001517 Neflamapimod Runs in: Netherlands; United States · 24 sites |
PHASE2 other |
COMPLETED | 91 | EIP Pharma Inc INDUSTRY |
2023-06-29 |
|
Acupuncture Therapy for Post-stroke Mild Cognitive Impairment: a Randomized Controlled Trial NCT05924308 electroacupuncture; sham acupuncture Runs in: China · 1 site |
NA other |
UNKNOWN | 60 | Shanghai University of Traditional Chinese Medicine OTHER |
2023-06-29 |
|
Alzheimer's Disease and Related Dementias (ADRD) Prevalence in American Samoa NCT05924529 Runs in: American Samoa · 2 sites |
NA other |
UNKNOWN | 1,098 | American Samoa Community Cancer Coalition OTHER |
2023-06-29 |
|
Smartphone App to Improve Physical Activity in Older Adults With MCI/Mild Dementia NCT04950998 Moving Up - A Runs in: United States · 1 site |
NA other |
COMPLETED | 21 | University of Southern California OTHER |
2023-06-27 |
|
Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease NCT00500500 EGb 761® (Tanakan®) Runs in: France · 1 site |
PHASE2 other |
TERMINATED | 40 | Ipsen INDUSTRY |
2023-06-26 |
|
Auditory Beat Stimulation and Behavioural Variant of Frontotemporal Dementia NCT05917886 Auditory beat stimulation: 8Hz monaural beat stimulation Runs in: Germany · 1 site |
NA other |
COMPLETED | 11 | University Hospital, Bonn OTHER |
2023-06-26 |
|
Protein and microRNA Markers for Early Detection of Alzheimer's Disease NCT03388242 No intervention Runs in: China · 2 sites |
NA other |
WITHDRAWN | 0 | Sun Yat-sen University OTHER |
2023-06-23 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial